Project/Portfolio Title

Management of Uncontrolled Type 2 Diabetes Mellitus with Combination Therapy with Metformin and/or Glucagon-like Peptide-1 Receptor Agonists/ Sodium-Glucose Cotransporter-2 Inhibitors

Author

Bertha L. Contreras, University of Texas at El Paso

Project Coversheet

Date of Award

4-2022

Degree Type

DNP Project

Degree Name

Doctor of Nursing (ND)

Department

Nursing

Chair

Hector R. Morales, DNP, APRN, PMG/CS-BC

Abstract

The management of chronic medical conditions in a primary care practice requires knowledge and commitment, particularly when providing services for the underserved. Type 2 diabetes mellitus (T2DM) is a complex and difficult condition that can result in complications that affect multiple organ systems. Numerous studies have described GLP-1RAs and SGLT-2is as complementary agents that can be used to prevent the multi-organ complications associated with T2DM. The purpose of this Quality Improvement (QI) Project is to introduce combination therapy with metformin and GLP-1RAs or SGLT-2is as part of an overall effort to address hyperglycemia in patients with uncontrolled T2DM. The foundations of this QI practice include a 10-day reflective practice in which T2DM was among the most frequent diagnoses. My findings revealed that current therapeutic strategies used to manage T2DM were not fully effective and might benefit from a change in practice. The implementation of this QI Project and the adoption of effective therapy improve the future care of patients with uncontrolled T2DM, their medication compliance, and their quality of life.

Recommended Citation

Contreras, Bertha L., "Management of Uncontrolled Type 2 Diabetes Mellitus with Combination Therapy with Metformin and/or Glucagon-like Peptide-1 Receptor Agonists/ Sodium-Glucose Cotransporter-2 Inhibitors" (2022). Cohort X. 18.
https://scholarworks.utep.edu/cohort_10/18